APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-Acting Contraceptive Pills

Compare research editions
View pricing & licenses

Selected research

Industry Research

Long-Acting Contraceptive Pills Industry Research Report 2026

28 December 2025118 pages

Choose your research edition.

Industry ResearchLong-Acting Contraceptive Pills Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Acting Contraceptive Pills Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Long-Acting Contraceptive Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Acting Contraceptive Pills Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Acting Contraceptive Pills Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Long-Acting Contraceptive Pills market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Long-Acting Contraceptive Pills is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Long-Acting Contraceptive Pills is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Long-Acting Contraceptive Pills include Bayer, Cipla, Merck, Sun Pharma, Teva Pharmaceuticals, Pfizer, Mylan, Shanghai Pharmaceuticals and Zhejiang Xianju Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Long-Acting Contraceptive Pills market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Long-Acting Contraceptive Pills Market by Company

Bayer

Cipla

Merck

Sun Pharma

Teva Pharmaceuticals

Pfizer

Mylan

Shanghai Pharmaceuticals

Zhejiang Xianju Pharmaceutical

Long-Acting Contraceptive Pills Segment by Type

Injectables

Subdermal Implants

Intrauterine Devices

Other

Long-Acting Contraceptive Pills Segment by Application

Hospital

Clinic

Long-Acting Contraceptive Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Contraceptive Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Long-Acting Contraceptive Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Long-Acting Contraceptive Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Long-Acting Contraceptive Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Long-Acting Contraceptive Pills Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Long-Acting Contraceptive Pills Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021-2026) Table 8. Global Long-Acting Contraceptive Pills Revenue of Manufacturers (2021-2026) Table 9. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Long-Acting Contraceptive Pills Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Long-Acting Contraceptive Pills Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Long-Acting Contraceptive Pills, Product Type & Application Table 14. Global Long-Acting Contraceptive Pills Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Long-Acting Contraceptive Pills by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bayer Company Information Table 19. Bayer Business Overview Table 20. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bayer Long-Acting Contraceptive Pills Product Portfolio Table 22. Bayer Recent Developments Table 23. Cipla Company Information Table 24. Cipla Business Overview Table 25. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Cipla Long-Acting Contraceptive Pills Product Portfolio Table 27. Cipla Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Merck Long-Acting Contraceptive Pills Product Portfolio Table 32. Merck Recent Developments Table 33. Sun Pharma Company Information Table 34. Sun Pharma Business Overview Table 35. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sun Pharma Long-Acting Contraceptive Pills Product Portfolio Table 37. Sun Pharma Recent Developments Table 38. Teva Pharmaceuticals Company Information Table 39. Teva Pharmaceuticals Business Overview Table 40. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 42. Teva Pharmaceuticals Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pfizer Long-Acting Contraceptive Pills Product Portfolio Table 47. Pfizer Recent Developments Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mylan Long-Acting Contraceptive Pills Product Portfolio Table 52. Mylan Recent Developments Table 53. Shanghai Pharmaceuticals Company Information Table 54. Shanghai Pharmaceuticals Business Overview Table 55. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 57. Shanghai Pharmaceuticals Recent Developments Table 58. Zhejiang Xianju Pharmaceutical Company Information Table 59. Zhejiang Xianju Pharmaceutical Business Overview Table 60. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio Table 62. Zhejiang Xianju Pharmaceutical Recent Developments Table 63. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (K Units) Table 65. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2026) Table 66. Global Long-Acting Contraceptive Pills Sales by Region (2027-2032) & (K Units) Table 67. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2027-2032) Table 68. Global Long-Acting Contraceptive Pills Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2026) Table 70. Global Long-Acting Contraceptive Pills Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2027-2032) Table 72. North America Long-Acting Contraceptive Pills Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 74. North America Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 75. North America Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Long-Acting Contraceptive Pills Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Long-Acting Contraceptive Pills Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 79. Europe Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 80. Europe Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Long-Acting Contraceptive Pills Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Long-Acting Contraceptive Pills Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 84. Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 85. Asia Pacific Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Long-Acting Contraceptive Pills Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Long-Acting Contraceptive Pills Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 89. South America Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 90. South America Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Long-Acting Contraceptive Pills Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 94. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 95. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 98. Global Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 99. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026) Table 100. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2027-2032) Table 101. Global Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026) Table 104. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2027-2032) Table 105. Global Long-Acting Contraceptive Pills Price by Type (2021-2026) & (US$/Unit) Table 106. Global Long-Acting Contraceptive Pills Price by Type (2027-2032) & (US$/Unit) Table 107. Global Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 108. Global Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 109. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026) Table 110. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2027-2032) Table 111. Global Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2026) Table 114. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2027-2032) Table 115. Global Long-Acting Contraceptive Pills Price by Application (2021-2026) & (US$/Unit) Table 116. Global Long-Acting Contraceptive Pills Price by Application (2027-2032) & (US$/Unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Long-Acting Contraceptive Pills Distributors List Table 120. Long-Acting Contraceptive Pills Customers List Table 121. Long-Acting Contraceptive Pills Industry Trends Table 122. Long-Acting Contraceptive Pills Industry Drivers Table 123. Long-Acting Contraceptive Pills Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Long-Acting Contraceptive Pills Product Image Figure 5. Global Long-Acting Contraceptive Pills Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Long-Acting Contraceptive Pills Market Size (2021-2032) & (US$ Million) Figure 7. Global Long-Acting Contraceptive Pills Sales (2021-2032) & (K Units) Figure 8. Global Long-Acting Contraceptive Pills Average Price (US$/Unit) & (2021-2032) Figure 9. Injectables Product Image Figure 10. Subdermal Implants Product Image Figure 11. Intrauterine Devices Product Image Figure 12. Other Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Long-Acting Contraceptive Pills Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Long-Acting Contraceptive Pills Sales by Region in 2025 Figure 21. Global Long-Acting Contraceptive Pills Revenue by Region in 2025 Figure 22. North America Long-Acting Contraceptive Pills Market Size by Country in 2025 Figure 23. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 24. North America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2032) Figure 25. United States Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Long-Acting Contraceptive Pills Market Size by Country in 2025 Figure 29. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 30. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2032) Figure 31. Germany Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Long-Acting Contraceptive Pills Market Size by Country in 2025 Figure 42. Asia Pacific Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2032) Figure 44. China Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Long-Acting Contraceptive Pills Market Size by Country in 2025 Figure 53. South America Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 54. South America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2032) Figure 55. Brazil Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country in 2025 Figure 59. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2032) Figure 61. Egypt Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Long-Acting Contraceptive Pills Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2032) Figure 67. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2032) Figure 68. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021-2032) Figure 69. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2032) Figure 70. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2032) Figure 71. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021-2032) Figure 72. Long-Acting Contraceptive Pills Value Chain Figure 73. Long-Acting Contraceptive Pills Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Long-Acting Contraceptive Pills Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injectables
  • Subdermal Implants
  • Intrauterine Devices
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Bayer
  • Cipla
  • Merck
  • Sun Pharma
  • Teva Pharmaceuticals
  • Pfizer
  • Mylan
  • Shanghai Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Long-Acting Contraceptive Pills Market Size (2021-2032)
  4. 2.2.2 Global Long-Acting Contraceptive Pills Sales (2021-2032)
  5. 2.2.3 Global Long-Acting Contraceptive Pills Market Average Price (2021-2032)
  6. 2.3 Long-Acting Contraceptive Pills by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injectables
  9. 2.3.3 Subdermal Implants
  10. 2.3.4 Intrauterine Devices
  11. 2.3.5 Other
  12. 2.4 Long-Acting Contraceptive Pills by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Long-Acting Contraceptive Pills Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Long-Acting Contraceptive Pills Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Long-Acting Contraceptive Pills Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Long-Acting Contraceptive Pills Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Long-Acting Contraceptive Pills Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Long-Acting Contraceptive Pills, Product Type & Application
  8. 3.8 Global Manufacturers of Long-Acting Contraceptive Pills, Established Date
  9. 3.9 Global Long-Acting Contraceptive Pills Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bayer
  2. 4.1.1 Bayer Company Information
  3. 4.1.2 Bayer Business Overview
  4. 4.1.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
  6. 4.1.5 Bayer Recent Developments
  7. 4.2 Cipla
  8. 4.2.1 Cipla Company Information
  9. 4.2.2 Cipla Business Overview
  10. 4.2.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
  12. 4.2.5 Cipla Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Long-Acting Contraceptive Pills Product Portfolio
  18. 4.3.5 Merck Recent Developments
  19. 4.4 Sun Pharma
  20. 4.4.1 Sun Pharma Company Information
  21. 4.4.2 Sun Pharma Business Overview
  22. 4.4.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
  24. 4.4.5 Sun Pharma Recent Developments
  25. 4.5 Teva Pharmaceuticals
  26. 4.5.1 Teva Pharmaceuticals Company Information
  27. 4.5.2 Teva Pharmaceuticals Business Overview
  28. 4.5.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  30. 4.5.5 Teva Pharmaceuticals Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Mylan
  38. 4.7.1 Mylan Company Information
  39. 4.7.2 Mylan Business Overview
  40. 4.7.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
  42. 4.7.5 Mylan Recent Developments
  43. 4.8 Shanghai Pharmaceuticals
  44. 4.8.1 Shanghai Pharmaceuticals Company Information
  45. 4.8.2 Shanghai Pharmaceuticals Business Overview
  46. 4.8.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  48. 4.8.5 Shanghai Pharmaceuticals Recent Developments
  49. 4.9 Zhejiang Xianju Pharmaceutical
  50. 4.9.1 Zhejiang Xianju Pharmaceutical Company Information
  51. 4.9.2 Zhejiang Xianju Pharmaceutical Business Overview
  52. 4.9.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
  54. 4.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
5 Global Long-Acting Contraceptive Pills Market Scenario by Region
  1. 5.1 Global Long-Acting Contraceptive Pills Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Long-Acting Contraceptive Pills Sales by Region: 2021-2032
  3. 5.2.1 Global Long-Acting Contraceptive Pills Sales by Region: 2021-2026
  4. 5.2.2 Global Long-Acting Contraceptive Pills Sales by Region: 2027-2032
  5. 5.3 Global Long-Acting Contraceptive Pills Revenue by Region: 2021-2032
  6. 5.3.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2021-2026
  7. 5.3.2 Global Long-Acting Contraceptive Pills Revenue by Region: 2027-2032
  8. 5.4 North America Long-Acting Contraceptive Pills Market Facts & Figures by Country
  9. 5.4.1 North America Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  11. 5.4.3 North America Long-Acting Contraceptive Pills Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Long-Acting Contraceptive Pills Market Facts & Figures by Country
  16. 5.5.1 Europe Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  18. 5.5.3 Europe Long-Acting Contraceptive Pills Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Long-Acting Contraceptive Pills Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Long-Acting Contraceptive Pills Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Long-Acting Contraceptive Pills Market Facts & Figures by Country
  41. 5.7.1 South America Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  43. 5.7.3 South America Long-Acting Contraceptive Pills Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Long-Acting Contraceptive Pills Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  2. 6.1.1 Global Long-Acting Contraceptive Pills Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2032)
  4. 6.2 Global Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  5. 6.2.1 Global Long-Acting Contraceptive Pills Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Long-Acting Contraceptive Pills Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  2. 7.1.1 Global Long-Acting Contraceptive Pills Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2032)
  4. 7.2 Global Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  5. 7.2.1 Global Long-Acting Contraceptive Pills Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Long-Acting Contraceptive Pills Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Long-Acting Contraceptive Pills Value Chain Analysis
  2. 8.1.1 Long-Acting Contraceptive Pills Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Long-Acting Contraceptive Pills Production Mode & Process
  5. 8.2 Long-Acting Contraceptive Pills Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Long-Acting Contraceptive Pills Distributors
  8. 8.2.3 Long-Acting Contraceptive Pills Customers
9 Global Long-Acting Contraceptive Pills Analyzing Market Dynamics
  1. 9.1 Long-Acting Contraceptive Pills Industry Trends
  2. 9.2 Long-Acting Contraceptive Pills Industry Drivers
  3. 9.3 Long-Acting Contraceptive Pills Industry Opportunities and Challenges
  4. 9.4 Long-Acting Contraceptive Pills Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst